Showing results (1211-1220 of 5,986) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|March 16, 2021
Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast CancerJessica L Christenson, Kathleen I O'Neill, Michelle M Williams, et al.
Molecular Cancer Therapeutics|March 16, 2021
Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug ConjugateMing-Chen Yang, Chi-Sheng Shia, Wan-Fen Li, et al.
Molecular Cancer Therapeutics|December 16, 2021
Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic AlterationsHitomi Jo, Shigehiro Yagishita, Yoshiharu Hayashi, et al.
Molecular Cancer Therapeutics|December 6, 2021
Abdominopelvic FLASH Irradiation Improves PD-1 Immune Checkpoint Inhibition in Preclinical Models of Ovarian CancerJoshua T Eggold, Stephanie Chow, Stavros Melemenidis, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Molecular Cancer Therapeutics|November 24, 2021
Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast CancerJames D Hampton, Erica J Peterson, Samantha J Katner, et al.
Molecular Cancer Therapeutics|October 11, 2022
Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor InhibitorsChristine Helsen, Tien T Nguyen, Xiao Yin Lee, et al.
Molecular Cancer Therapeutics|September 13, 2022
p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 InhibitionFelix Oppel, Senyao Shao, Sarah Gendreizig, et al.
Molecular Cancer Therapeutics|September 19, 2022
Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein βEmad Darvishi, Lila Ghamsari, Siok F Leong, et al.
Molecular Cancer Therapeutics|October 5, 2022
External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate CancerUmang Swami, Nicolas Sayegh, Yeonjung Jo, et al.
Pageof 599